FSA
PCRX icon

Franklin Street Advisors’s Pacira BioSciences PCRX Stock Holding History

Franklin Street Advisors’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-12,325
Closed -$653K – 213
2016
Q1 		$653K Buy
12,325
+6,125
+99% +$358K 0.13% 123
2015
Q4 		$476K Buy
+6,200
New +$351K 0.09% 146
2015
Q3 		– Sell
-4,050
Closed -$287K – 234
2015
Q2 		$287K Sell
4,050
-900
-18% -$70.9K 0.05% 187
2015
Q1 		$439K Sell
4,950
-675
-12% -$68.5K 0.08% 144
2014
Q4 		$499K Sell
5,625
-2,150
-28% -$203K 0.1% 134
2014
Q3 		$754K Hold
7,775
– – 0.14% 135
2014
Q2 		$714K Sell
7,775
-2,925
-27% -$223K 0.14% 146
2014
Q1 		$749K Sell
10,700
-4,425
-29% -$301K 0.15% 142
2013
Q4 		$870K Sell
15,125
-6,525
-30% -$343K 0.18% 124
2013
Q3 		$1.04M Sell
21,650
-8,450
-28% -$308K 0.23% 103
2013
Q2 		$873K Buy
+30,100
New +$871K 0.21% 126

Other funds holding PCRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return